跳至主要内容
临床试验/IRCT2017052034038N1
IRCT2017052034038N1已完成3 期

Simultaneous use of chromium picolinate and vitamin D reconstruction or prevention of endothelial dysfunction in patients with type 2 diabetes by examining the pattern of changes in metabolic markers of oxidative stress, inflammation and endothelial dysfunction

Khomein University of Medical Sciences0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 60 years(—)
性别
All

入选标准

  • ( patients with type 2 diabetes for a maximum of 5 years; 25 to 60 years ages; with metformin as a hypoglycemic medication)
  • (Exclusion criteria: patients with Insulin injection; inflammatory diseases; kidney disease; liver disease; parathyroid disease; pregnancy and lactation; taking anticonvulsants and steroids; history of tobacco; the use of supplements and minerals ; patients with hypertension and hypothyroidism)

排除标准

  • 未提供

研究者

发起方
Khomein University of Medical Sciences

相似试验

Prevention of endothelial dysfunction in patients... | 临床试验